Literature DB >> 10583071

The HECA-452 epitope is highly expressed on lymph cells derived from human skin.

R E Hunger1, N Yawalkar, L R Braathen, C U Brand.   

Abstract

The cutaneous lymphocyte-associated antigen (CLA), recognized by the monoclonal antibody HECA-452, is a cell surface glycoprotein that binds specifically to E-selectin. CLA is present on most T cells at sites of cutaneous immune response and has been shown to be important in lymphocyte homing to the skin. It is expressed only by a minor subset of peripheral T cells and is absent on thymocytes. We have analysed (using a FACScan flow cytometer) the expression of CLA on human lymph cells derived from normal skin, from ultraviolet (UV)-irradiated skin and from allergic contact dermatitis. Whereas in the peripheral blood CLA was expressed on < 20% of CD4 +, CD8 + and CD56 + cells (natural killer cells), > 60% of CD4 +, CD8 + and CD56 + cells isolated from skin-derived lymph expressed CLA. Furthermore, > 90% of CD1a + dendritic lymph cells were positive for CLA. UV irradiation of the skin and induction of an allergic contact dermatitis did not change CLA expression on lymph cells, although lymph flow and cell output increased. These results provide further evidence for an important role of CLA in cell homing to the skin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583071     DOI: 10.1046/j.1365-2133.1999.03031.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis.

Authors:  Carmen Gerlach; E Ashley Moseman; Scott M Loughhead; David Alvarez; Anthonie J Zwijnenburg; Lisette Waanders; Rohit Garg; Juan C de la Torre; Ulrich H von Andrian
Journal:  Immunity       Date:  2016-12-06       Impact factor: 31.745

Review 3.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

4.  Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis.

Authors:  Madeliene E Gainers; Leyla Descheny; Steven R Barthel; Luzheng Liu; Marc-André Wurbel; Charles J Dimitroff
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

5.  Natural killer cell distribution and trafficking in human tissues.

Authors:  Paolo Carrega; Guido Ferlazzo
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

6.  Natural Killer Cells in Afferent Lymph Express an Activated Phenotype and Readily Produce IFN-γ.

Authors:  Hege Lund; Preben Boysen; Jayne C Hope; Siri K Sjurseth; Anne K Storset
Journal:  Front Immunol       Date:  2013-11-22       Impact factor: 7.561

7.  Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood.

Authors:  Carly A Hamilton; Suman Mahan; Charlotte R Bell; Bernardo Villarreal-Ramos; Bryan Charleston; Gary Entrican; Jayne C Hope
Journal:  Immunology       Date:  2017-02-07       Impact factor: 7.397

8.  Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen.

Authors:  Li-Fang Wang; Jau-Shiuh Chen; Chih-Jung Hsu; Ching-Yi Liu; Jhang-Sian Yu; Shi-Chuen Miaw
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

Review 9.  The trafficking of natural killer cells.

Authors:  Claude Grégoire; Lionel Chasson; Carmelo Luci; Elena Tomasello; Frédéric Geissmann; Eric Vivier; Thierry Walzer
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

Review 10.  Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues.

Authors:  Roberta Castriconi; Paolo Carrega; Alessandra Dondero; Francesca Bellora; Beatrice Casu; Stefano Regis; Guido Ferlazzo; Cristina Bottino
Journal:  Front Immunol       Date:  2018-10-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.